MarketInOut Stock Screener Log In | Sign Up
 

Achieve Life Sciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/18/2026 16:00
Achieve Life Sciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization766.62 mln
Float102 mln
Earnings Date11/05/2026

Piotroski F-Score

2 / 9
Weak

1-Year Forecast

13.83
Transformational upside

Relative Strength

30 / 100
Underperforming

ROE

-614
Deeply negative

ROA

-152
Deeply negative

Business Description

Achieve Life Sciences is a pharmaceutical company based in Bothell, Washington, focused on helping people quit smoking. Its lead product, cytisinicline, is a naturally derived compound that works by targeting nicotine receptors in the brain, easing the discomfort of withdrawal. The company operates across the United States, Canada, and the United Kingdom, supported by agreements with Sopharma AD and the University of Bristol for licensing and supply.

Key Fundamentals

EPS-1.66
ROE-614
ROIC-127
ROA-152
Interest Cover-58.63
EBITDA, mln-113
EV / EBITDA-5.87
EV / EBIT-5.86

Financial Strength

Piotroski F-Score 2 / 9
1-Year Target Price13.83
Short Ratio12.35
Short % of Float16.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 13.03% 96 / 100   
1 Month -6.45% 27 / 100   
2 Months 44.57% 95 / 100   
6 Months 95.11% 97 / 100   
1 Year 170% 98 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us